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ABSTRACT
We investigated the influence of bone marrow cells upon activation of ERK ½ in an 
animal model of 90% PH. Phosphorylated ERK 1/2 was evaluated by western blot. 
No differences were found between the groups. Thus, increased survival does not 
appear to be mediated by ERK 1/2 activation.
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Acute liver failure (ALF) is defined as a sudden loss of hepatic function 
leading to jaundice, coagulopathy and encephalopathy in previously healthy 
individuals. ALF can originate from different causes, such as toxic or viral 
agents and resection of liver mass1.
Cell therapy protocols with bone marrow-derived cells have shown promising 
results increasing the speed of hepatic regeneration2-4. The mechanism of 
action of these cells is not completely understood but different mechanisms 
have been suggested, including paracrine effects3,5,6. In a previous study 
from our group we have shown that encapsulated whole-bone marrow cells 
(WBM) increase 10-day survival after 90%HP in 50% when compared with the 
control group (5%) by decreasing the expression of liver regenerating factors6. 
A previous observation that decreased liver regeneration rate is beneficial 
after massive hepatocyte loss has been reported by Ninomyia et al.7. These 
authors suggest that inhibition of ERK1/2 leads to a balanced cell division 
between hepatocytes and sinusoids epithelial cells. In order to investigate if 
this mechanism could be operating in our model we analyzed ERK 1/2 and 
AKT phosphorylation status and mitotic index in 90%HP animals receiving 
encapsulated WBM.
METHOD
To achieve our goals, we used samples of liver obtained from the study 
published by Uribe-Cruz et al.6. Briefly, Wistar rats were submitted to 
90%PH. WBM cells were isolated from donor rat’s and were encapsulated 
as described by Baldo et al.8 and Lagranha et al.9 respectively without prior 
culture. Microcapsules were implanted in the peritoneum immediately after 
90% partial hepatectomy. WBM group received 3x107 cells encapsulated 
in semipermeable alginate beads, whereas control group received empty 
capsules (EC). Animals were euthanized at 6, 12, 24, 48, and 72 hours 
post-surgery (n=5 animals/time/group). Part of the remaining liver was snap 
frozen in liquid nitrogen then stored at -80ºC. This study was approved by 
the Ethics Committee on Animal Research at Hospital de Clíncas de Porto 
Alegre (GPPG-12-0114).
ERK 1/2 activation was analyzed in liver extracts (0.2 g) macerated in 
1 mL lysis buffer (HEPES 0,25 mM, Tris 10 mM, EDTA 1 mM, Na3VO 1mM 
e NaF 10 mM em ph 7,4) containing protease inhibitors (1%) and centrifuged 
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for 30 minutes at 15000 g at 4°C. Protein quantity 
was determined by Bradford assay10. After 5 minutes 
at 100 °C samples were separated on PAGE 10% 
and transferred to PVDF membrane (MiliPore) by 
wet blotting. Membranes were blocked in solution 
containing 5% powdered milk diluted in PBS-Tween 
(0.05%) for 30 minutes and then hybridized with 
antibodies for phospho-ERK 1/2 (Cell Signaling 
Technologies, USA) at 4 ºC for 12 hours. Membranes 
were exposed to horse-raddish peroxidase conjugated 
secondary antibody (Sigma-Aldrich, USA) for 1 hour 
at room temperature. Membranes were revealed 
with ECL kit (BioRad). The density of the specific 
bands was quantified with imaging density software 
(Image J, USA).
Statistical analysis was performed on PASW 
Statistic 18. Results are expressed as mean with 
SD and analyzed using One Way ANOVA, P values 
p<0.05 were considered significant.
RESULTS
The expression pattern of phosphorylated ERK 1/2 
at different time points is shown in Figure 1. An increase 
in activated (phosphorylated) ERK 1/2 at 12 hours was 
observed for EC group compared to 6, 24 and 72 hours 
after 90% PH (P<0.05); whereas WBM group 
showed an increase at 12 hours when compared 
at 6 and 72 hours only (p<0.05). No difference was 
found on ERK 1/2 at any time point between both 
groups, although there was a trend for increase in 
phosphorylated ERK 1/2 at 24 hours after 90% PH 
in WBM group (p=0.07).
DISCUSSION
The liver has an impressive regenerative capacity 
due to the ability of mature hepatocytes to enter cell 
cycle upon damaging stimuli. In a previous work 
we observed that bone marrow cells entrapped in 
alginate microcapsules increase 10-day survival in 
a murine model of 90% HP6. The present study was 
conducted to investigate if the beneficial effect of 
bone marrow cells could be due to ERK 1/2 activity.
Murata et al.11 showed a progressive decrease in 
ERK 1/2 2 and 6 hours after 70% PH in animals with 
thrombocytosis, suggesting that this is a protective 
effect mediated by increased platelet levels. On the 
other hand, Ninomiya et al.7 showed that blocking 
ERK 1/2 activation with a specific drug results in 
decreased hepatocyte proliferation and increased 
survival. In the present study there was no difference 
between groups regarding ERK1/2 activation, although 
there was a trend for increase in phosphorylated ERK 
1/2 at 24 hours after 90% PH in the group receiving 
encapsulated bone marrow cells.
Probably the responses elicited by bone marrow 
cells vary according to the type of lesion, or even 
that increased proliferation is dependent on cell-cell 
contact, which is impossible in our model as cells 
are encapsulated6.
In conclusion, the present study showed that other 
mechanisms must be investigated in order to explain 
this difference in this model of acute liver failure.
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Figure 1: (A) Western Blot showing ERK 1/2 activation in 
WBM and EC groups at 6, 12, 24 and 72 hours after 90% 
PH; (B) Relative intensity of ERK 1/2 bands (normalized 
by Actin bands) of both groups in the same time points. # 
p<0.05 72 vs 6 and 12 hours EC group and *p<0.05 72 vs 6 
and 12 hours WBM group (one-way ANOVA).
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